THN-1

N/A

Report date: 2025/01/26 17:14:00
NME

Base Information

Drug NameTHN-1
Drug Alias NameTHN-1
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionSuperoxide dismutase modulators
TargetsSuperoxide dismutase
Therapy Area/IndicationsAmyotrophic Lateral SclerosisNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThera Neuropharma
China Registration ClassN/A

Develop Information

Active CompaniesThera Neuropharma
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A